-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Arvinas, Lowers Price Target to $16

Benzinga·05/02/2025 13:33:53
Listen to the news
Barclays analyst Peter Lawson maintains Arvinas (NASDAQ:ARVN) with a Overweight and lowers the price target from $32 to $16.